Cancer Immunotherapy Paradigms, Practice and Promise
This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical tr...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY
Springer New York
2013, 2013
|
| Edition: | 1st ed. 2013 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Introduction
- Historical Perspectives and Current Trends in Cancer Immunotherapy
- T cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
- Adoptive T Cell Transfer
- Dendritic Cell-Based Cancer Immunotherapy: Achievements and novel concepts
- Peptide and Protein-based Cancer Vaccines
- Antigen Targeting to Dendritic Cells for Cancer Immunotherapy
- Cytokines in the Treatment of Cancer
- Immune Co-signaling to Treat Cance
- Managing Regulatory T cells
- Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and therapeutic perspectives
- Antibodies as Cancer Immunotherapy
- Targeted Toxins in Cancer Immunotherapy
- Miscellaneous Approaches and Considerations: TLR agonists and other inflammatory agents, anti-chemokine agents, infectious agents, tumor stroma targeting, age and sex effects, and miscellaneous small molecules
- Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies
- Monitoring Antigen-Specific Responses in Clinical Trials of Immunotherapy
- Index